TherapeuticsMD, Inc.

    Jurisdiction
    United States
    LEI
    5299004JS7RE49QHRW30
    ISIN
    US88338N2062 (TXMD)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €2.20M
    Gross margin
    92.3%
    EBIT
    -€2.35M
    EBIT margin
    -107.2%
    Net income
    -€393.82K
    Net margin
    -17.9%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: August 15, 2022

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 14K $12.49K +2.6K Buy

    Add to watchlist

    Notifications